LINGBAO GOLD (03330): Major progress has been made in the exploration work of Huatai Company in Habahe, Xinjiang, with the gold metal reserves (mineral resources) soaring to 53.94 tons.
Lingbao Gold (03330) announced that its subsidiary, Huatai Gold Co., Ltd. (Huatai Company), located in the Habahe area of Altay, Xinjiang, as well as its affiliated subsidiary Habahe Huayuan Mining Co., Ltd. (Huayuan Company), which is 60% indirectly owned by the Company, has made significant progress in its overall exploration work. As of June 30, 2026, the estimated resource amount has surged from 13.20 tons at the end of 2025 (as disclosed in the Company's 2025 annual report) to 53.94 tons.
LINGBAO GOLD (03330) announced that its wholly-owned subsidiary, Habahe Huatai Gold Limited Liability Company (Huatai Company), located in the Altay region of Xinjiang, and its subsidiary Habahe Huayuan Mining Co., Ltd. (Huayuan Company), which is not wholly-owned and is indirectly 60% owned by the company, have made significant progress in their overall exploration work. As of June 30, 2026, the estimated resource amount has increased from 13.20 tons at the end of 2025 (as disclosed in the company's 2025 annual report) to 53.94 tons. This mineral resource report was prepared by Beijing SRK Resource Technology Co., Ltd. (SRK) in accordance with the 2012 edition of the Australasian Code for Reporting Exploration Results, Mineral Resources and Ore Reserves (JORC Code).
Related Articles
INKEVERSE (03700) issues a profit warning, expecting that net profit for the first half of the year will decline by more than 30.0% year-on-year.
JD HEALTH (06618) launched 65 new drugs in the first half of the year, leading the industry, with pharmaceutical sales maintaining the top position in the sector.
.png)
Jl Mag Rare-Earth (06680): Termination of subscription for shares of Australian-listed rare earth company Hastings.
INKEVERSE (03700) issues a profit warning, expecting that net profit for the first half of the year will decline by more than 30.0% year-on-year.
JD HEALTH (06618) launched 65 new drugs in the first half of the year, leading the industry, with pharmaceutical sales maintaining the top position in the sector.
Jl Mag Rare-Earth (06680): Termination of subscription for shares of Australian-listed rare earth company Hastings.
RECOMMEND
